Welcome to LookChem.com Sign In|Join Free
  • or

103890-78-4

Post Buying Request

103890-78-4 Suppliers

Recommended suppliersmore

Product FOB Price Min.Order Supply Ability Supplier
Lacidipine Manufacturer/High quality/Best price/In stock
Cas No: 103890-78-4
USD $ 3.0-3.0 / Kilogram 1 Kilogram 1-100 Metric Ton/Month Hangzhou Dayangchem Co., Ltd. Contact Supplier
Lacidipine
Cas No: 103890-78-4
No Data 1 Kilogram 1 Metric Ton/Month Henan Allgreen Chemical Co.,Ltd Contact Supplier
High quality Lacidipine supplier in China
Cas No: 103890-78-4
No Data No Data No Data Simagchem Corporation Contact Supplier
Lacidipine
Cas No: 103890-78-4
No Data No Data No Data Chemwill Asia Co., Ltd. Contact Supplier
Hot sale 103890-78-4 Lacidipine with best price
Cas No: 103890-78-4
USD $ 1000.0-1500.0 / Kilogram 1 Kilogram 100 Metric Ton/Month Crovell Biotech (Hebei) Co., Ltd. Contact Supplier
Lacidipine
Cas No: 103890-78-4
No Data 100 Gram 100 Kilogram/Month HENAN SUNLAKE ENTERPRISE CORPORATION Contact Supplier
High purity 99% Lacidipine in stock manufacturer
Cas No: 103890-78-4
No Data 1 Gram 1 Metric Ton/Week Shaanxi Mingqi Chemical Co., Ltd Contact Supplier
99%min Lacidipine 103890-78-4
Cas No: 103890-78-4
No Data 10 Gram 1000 Metric Ton/Month Hubei XinRunde Chemical Co., Ltd Contact Supplier
Lacidipine CAS NO.103890-78-4 top supplier with low price
Cas No: 103890-78-4
No Data 1 Kilogram 100 Metric Ton/Week HUBEI AOKS BIO-TECH CO.,LTD Contact Supplier
Manufacturer supply Lacidipine CAS 103890-78-4 of BP standard
Cas No: 103890-78-4
USD $ 620.0-700.0 / Kilogram 1 Kilogram 2000 Kilogram/Month Wuhan Fortuna Chemical Co.,Ltd Contact Supplier

103890-78-4 Usage

Chemical Properties

White-to-Off-White Crystalline Solid

Uses

A dihydropyridine calcium channel blocker. Antihypertensive

Uses

antihypertensive;dihydropyridinr calcium channel blocker
InChI:InChI=1/C26H33NO6/c1-8-31-24(29)21-16(3)27-17(4)22(25(30)32-9-2)23(21)19-13-11-10-12-18(19)14-15-20(28)33-26(5,6)7/h10-15,23,27H,8-9H2,1-7H3/b15-14+

103890-78-4 Well-known Company Product Price

Brand (Code)Product description CAS number Packaging Price Detail
Sigma (SML0946)  Lacidipine  ≥98% (HPLC) 103890-78-4 SML0946-50MG 2,975.31CNY Detail
Sigma (SML0946)  Lacidipine  ≥98% (HPLC) 103890-78-4 SML0946-10MG 734.76CNY Detail
TCI America (L0276)  Lacidipine  >98.0%(HPLC)(N) 103890-78-4 1g 2,590.00CNY Detail
TCI America (L0276)  Lacidipine  >98.0%(HPLC)(N) 103890-78-4 200mg 790.00CNY Detail

103890-78-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate

1.2 Other means of identification

Product number -
Other names Motens

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103890-78-4 SDS

103890-78-4Related news

Formulation and optimization of Lacidipine (cas 103890-78-4) loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity07/25/2019

The aim of the present research work is to formulate lacidipine (LAC) loaded niosomes formulation for the management of hypertension by thin film hydration technique. The developed formulations were statistically optimized by four factors, three levels Box–Behnken design and were evaluated for ...detailed

Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral Lacidipine (cas 103890-78-4) formulations in dogs07/24/2019

The aim of the present study was to investigate virtual population pharmacokinetic using physiologically based pharmacokinetic (PBPK) model for evaluating bioequivalence of oral lacidipine formulations in dogs. The dissolution behaviors of three lacidipine formulations including one commercial p...detailed

Rapidly dissolving Lacidipine (cas 103890-78-4) nanoparticle strips for transbuccal administration07/22/2019

The purpose of this study was to prepare fast-dissolving film strips containing lacidipine (LCDP) nanoparticles for transbuccal administration. Nanoparticles were prepared using the solvent-antisolvent sonoprecipitation technique. The influence of different antisolvent phase stabilizers on parti...detailed

Lacidipine (cas 103890-78-4) attenuates TNF-α-induced cardiomyocyte apoptosis07/20/2019

This study was designed to investigate whether lacidipine elicited a protective role on cardiomyocyte against apoptosis induced by TNF-α. Neonatal rat cardiomyocytes were randomly assigned into different groups. TUNEL staining was utilized to detect apoptosis, and caspase-3 and caspse-12 were d...detailed

Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable Lacidipine (cas 103890-78-4) solid dispersion07/21/2019

Limited supersaturation maintaining duration is the main challenge for amorphous solid dispersion design. Nucleation or crystal growth inhibitors may function in different ways but the combination use of nucleation and crystal growth inhibitors in supersaturated system is rarely explored. Thus, ...detailed

Please post your buying leads,so that our qualified suppliers will soon contact you!

*Required Fields